Supreme Court: State Must Be Impleaded When Relief is Sought From Public Exchequer || SC: Student Fees Cannot Be Increased Mid-Course Except in Exceptional Circumstances || Supreme Court: ED's Delay in Sending Arrest Order Does Not By Itself Invalidate Arrest || Supreme Court: Appeal Limitation Runs From NCLAT Order Pronouncement, Not Certified Copy Receipt || Gujarat High Court: Waqf Tribunal Has No Supervisory Authority Over Waqf Board || Kerala High Court Orders Aadhaar Fingerprint Comparison to Trace Sreekrishnapuram Murder Culprits || Delhi High Court: Unnatural Death at Police Station Alone Cannot Establish Police Negligence || Orissa High Court: Teacher Scolding Student for Intoxicant Use is Not Suicide Abetment || Supreme Court: Drug Users are Victims and Focus Must Be on Breaking the Supply Chain || Supreme Court: Non-Signatories May Join Arbitration When the Dispute Affects Their Rights

Drugs and Cosmetics (Amendment) Bill 2013 shelved - (22 Jun 2016)

Commercial

The Union Cabinet approved withdrawal of the Drugs and Cosmetics (Amendment) Bill 2013 from the Rajya Sabha.

Having been sent for examination, the Parliamentary Standing Committee recommended a plethora of changes to the Bill in light of rapid development in the pharmaceutical and cosmetic industries. The government will now rework the Bill comprehensively to encompass recent advances in research and development, and promoting a higher quality of products.

The Bill was tabled in Parliament on 29 August 2013, shortly after which it was referred to the Parliamentary Standing Committee on Health and Family Welfare.

Tags : DRUGS AND COSMETICS PHARMACEUTICAL CLINICAL TRIALS

Share :